Anelto Partners with BioIntelliSense

THE COLONY, TEXAS (April 28, 2022)—Anelto, a provider of remote patient monitoring (RPM) solutions, announced it has entered into a channel partnership with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to integrate BioIntelliSense’s FDA-cleared BioSticker and BioButton wearable medical devices and data services with Anelto’s RemoteCareLive! RPM platform. The collaboration strengthens Anelto’s proven leadership in delivering patient-centric, feature-rich health care solutions to provide better experiences and outcomes for seniors with complex or chronic care management needs.

Anelto’s RemoteCareLive! Suite of RPM solutions is designed specifically for seniors, collecting vital signs, conducting telehealth visits with a physician and delivering healthy lifestyle tips—all from a purpose-built health care console. RemoteCareLive! makes it simple for patients to set up and easily take their own vital signs, including blood pressure, weight, pulse oximetry, and now continuous vital sign and biometric data effortlessly with BioIntelliSense. Health care professionals can monitor this data in near real-time and longitudinally to spot trends that need immediate action or further monitoring. Integration with BioIntelliSense allows high frequency patient trending data and alerting to be collected through the flagship BioSticker and award-winning BioButton wearable medical devices for patients who benefit most from continuous passive monitoring.

“Anelto has tens of thousands of patients using our advanced remote patient monitoring solutions in North America,” said Anelto CEO Mark Denissen. “Our relationship with BioIntelliSense allows us to continue to serve those patients while offering additional solutions to a broader range of patients. We believe the partnership will help us increase ease of use and regular reporting for patients who need additional help remembering to take their vital signs consistently. In addition, Anelto brings efficiencies and scale to enable a better economic model for our healthcare provider partners.”

The BioIntelliSense solutions enable passive measurement of up to 1,440 sets of vital signs, symptoms and biometrics per day. The RemoteCareLive! platform auto-detects the BioIntelliSense wearable devices and securely transmits the medical-grade trending data and alerting for dynamic display and proactive clinical decisions within Anelto’s clinical tool suite, which is fully configurable to a healthcare provider’s monitoring requirements.

The BioIntelliSense multi-parameter solutions have a long battery life, offering continuous monitoring for 30 days and beyond with a leading portfolio of single-use wearable medical devices. BioIntelliSense recently launched a rechargeable version of its BioButton monitoring solution, which continuously monitors more than 20 vital signs and physiologic biometrics for up to 30 days on a single charge for effectively managing patient populations with long-term chronic, complex care needs.

“BioIntelliSense is proud of its collaboration with Anelto in creating an effortless user experience for senior monitoring within facilities and home settings,” said James Mault, MD, Founder and CEO of BioIntelliSense. “Our integration with the RemoteCareLive! platform provides a comprehensive solution that leverages BioIntelliSense’s clinically validated and continuous trending data, along with algorithmic-based alerting, to provide scalable peace-of-mind remote monitoring for vulnerable senior patient populations.”

Visit anelto.com and biointellisense.com for more information.